Neurogene (NGNE) Reports In-Line Q3 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- S&P 500, Nasdaq set to open higher as AI stocks rebound ahead of earnings rush
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Oil slips from five-month high with Hormuz transits in focus
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
Tweet
Share
E-mailGet Alerts NGNE Hot Sheet
Join SI Premium – FREE
Neurogene (NASDAQ: NGNE) reported Q3 EPS of ($1.19), in-line with the analyst estimate of ($1.19).
For earnings history and earnings-related data on Neurogene (NGNE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- StoneX Reiterates Hold Rating on Meta Platforms Inc. (META) Ahead of Q3 Earnings
- NiSource (NI) PT Raised to $48 at BMO Capital
- Carter's (CRI) PT Lowered to $38 at UBS Ahead of Q3 Earnings
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
